Condition of the hemostatic system in pregnant women with the threat of premature birth when using metabolic therapy

Abstract

130 pregnant women were examined with the threat of premature birth in the gestational age of 28-34 weeks: I group – 67 pregnant women with threatened preterm labor who received standard complex therapy in combination with metabolic therapy in the form of 300 mg of omega-3 polyunsaturated fatty acidsper day, group II - 63 pregnant women with threatened preterm labor who received only standard complextherapy. Analyzing the state of the hemostasis system, the following changes were revealed: an increase in the level of fibrinogen and prothrombin time, indicating a hypercoagulative process.Were observed a decrease in fibrinogen level, an increase in platelet count and activated partial thromboplastin time and a decrease in prothrombin time after treatment with the use of metabolic therapy, indicating the antithrombotic and antiaggregatory effects of metabolic therapy.